Published in Proc Natl Acad Sci U S A on April 25, 1995
Long-term potentiation depends on release of D-serine from astrocytes. Nature (2010) 4.36
D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A (2000) 3.71
Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior. Annu Rev Physiol (2010) 3.38
Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission. Proc Natl Acad Sci U S A (1999) 3.15
Contribution of astrocytes to hippocampal long-term potentiation through release of D-serine. Proc Natl Acad Sci U S A (2003) 2.35
NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology (Berl) (2003) 2.28
Purification of serine racemase: biosynthesis of the neuromodulator D-serine. Proc Natl Acad Sci U S A (1999) 2.27
Glutamate receptor activation triggers a calcium-dependent and SNARE protein-dependent release of the gliotransmitter D-serine. Proc Natl Acad Sci U S A (2005) 2.06
Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior. Mol Psychiatry (2008) 1.88
Heterogeneity of astrocytic form and function. Methods Mol Biol (2012) 1.83
Storage and uptake of D-serine into astrocytic synaptic-like vesicles specify gliotransmission. J Neurosci (2013) 1.82
Neuronal nitric oxide synthase alternatively spliced forms: prominent functional localizations in the brain. Proc Natl Acad Sci U S A (1997) 1.73
Serine racemase: activation by glutamate neurotransmission via glutamate receptor interacting protein and mediation of neuronal migration. Proc Natl Acad Sci U S A (2005) 1.68
Gliotransmission: Exocytotic release from astrocytes. Brain Res Rev (2009) 1.68
D-serine and serine racemase are present in the vertebrate retina and contribute to the physiological activation of NMDA receptors. Proc Natl Acad Sci U S A (2003) 1.57
Synaptotagmin IV regulates glial glutamate release. Proc Natl Acad Sci U S A (2004) 1.46
TRPA1 channels are regulators of astrocyte basal calcium levels and long-term potentiation via constitutive D-serine release. J Neurosci (2013) 1.36
Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration. Antioxid Redox Signal (2009) 1.34
Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia. Schizophr Bull (2012) 1.33
Cofactors of serine racemase that physiologically stimulate the synthesis of the N-methyl-D-aspartate (NMDA) receptor coagonist D-serine. Proc Natl Acad Sci U S A (2002) 1.32
Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction. Proc Natl Acad Sci U S A (2013) 1.31
D-aspartate localizations imply neuronal and neuroendocrine roles. Proc Natl Acad Sci U S A (1997) 1.31
d-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia. Eur J Neurosci (2007) 1.29
Glial modulation of synaptic transmission in the retina. Glia (2004) 1.28
D-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis. EMBO J (2007) 1.26
Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology. Genes Brain Behav (2010) 1.25
Induction of serine racemase expression and D-serine release from microglia by amyloid beta-peptide. J Neuroinflammation (2004) 1.25
Molecular signals of plasticity at the tetrapartite synapse. Curr Opin Neurobiol (2011) 1.20
Cell selective conditional null mutations of serine racemase demonstrate a predominate localization in cortical glutamatergic neurons. Cell Mol Neurobiol (2012) 1.12
Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications. Handb Exp Pharmacol (2012) 1.12
The neurobiology of D-amino acid oxidase and its involvement in schizophrenia. Mol Psychiatry (2009) 1.12
Calcium signaling in specialized glial cells. Glia (2006) 1.12
Neuronal release of D-serine: a physiological pathway controlling extracellular D-serine concentration. FASEB J (2010) 1.12
Astrocytic control of synaptic transmission and plasticity: a target for drugs of abuse? Neuropharmacology (2008) 1.11
N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives. Psychopharmacology (Berl) (2005) 1.11
The NMDA receptor 'glycine modulatory site' in schizophrenia: D-serine, glycine, and beyond. Curr Opin Pharmacol (2014) 1.11
Coagonist release modulates NMDA receptor subtype contributions at synaptic inputs to retinal ganglion cells. J Neurosci (2009) 1.09
Glutamatergic regulation of serine racemase via reversal of PIP2 inhibition. Proc Natl Acad Sci U S A (2009) 1.09
D-Serine differently modulates NMDA receptor function in rat CA1 hippocampal pyramidal cells and interneurons. J Physiol (2003) 1.08
Astrocytic activation of A1 receptors regulates the surface expression of NMDA receptors through a Src kinase dependent pathway. Glia (2011) 1.08
The NMDA receptor co-agonists, D-serine and glycine, regulate neuronal dendritic architecture in the somatosensory cortex. Neurobiol Dis (2011) 1.04
Astrocytic calcium signaling: mechanism and implications for functional brain imaging. Methods Mol Biol (2009) 1.04
Glia-derived signals induce synapse formation in neurones of the rat central nervous system. J Physiol (2001) 1.02
Feedback inactivation of D-serine synthesis by NMDA receptor-elicited translocation of serine racemase to the membrane. Proc Natl Acad Sci U S A (2009) 1.02
D-amino acid oxidase generates agonists of the aryl hydrocarbon receptor from D-tryptophan. Chem Res Toxicol (2009) 1.01
The N-methyl D-aspartate receptor glycine site and D-serine metabolism: an evolutionary perspective. Philos Trans R Soc Lond B Biol Sci (2004) 0.99
Genetic inactivation of D-amino acid oxidase enhances extinction and reversal learning in mice. Learn Mem (2008) 0.98
The role of astrocytes in the regulation of synaptic plasticity and memory formation. Neural Plast (2013) 0.98
A new strategy to decrease N-methyl-D-aspartate (NMDA) receptor coactivation: inhibition of D-serine synthesis by converting serine racemase into an eliminase. Proc Natl Acad Sci U S A (2001) 0.96
Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia. Schizophr Res (2008) 0.96
D-serine facilitates the effects of extinction to reduce cocaine-primed reinstatement of drug-seeking behavior. Neurobiol Learn Mem (2009) 0.96
D-serine in glia and neurons derives from 3-phosphoglycerate dehydrogenase. J Neurosci (2013) 0.95
Astrocytes as secretory cells of the central nervous system: idiosyncrasies of vesicular secretion. EMBO J (2016) 0.95
Evolution of neuronal and astroglial disruption in the peri-contusional cortex of mice revealed by in vivo two-photon imaging. Brain (2013) 0.95
Astrocyte-induced cortical vasodilation is mediated by D-serine and endothelial nitric oxide synthase. Proc Natl Acad Sci U S A (2013) 0.95
D-serine and serine racemase are localized to neurons in the adult mouse and human forebrain. Cell Mol Neurobiol (2014) 0.95
Trafficking and fusion of neuropeptide Y-containing dense-core granules in astrocytes. J Neurosci (2008) 0.95
D-Serine as a putative glial neurotransmitter. Neuron Glia Biol (2004) 0.94
The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies. Ann N Y Acad Sci (2014) 0.92
Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site. Eur Arch Psychiatry Clin Neurosci (2007) 0.92
Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence? Front Neurosci (2015) 0.92
Susceptibility to Calcium Dysregulation during Brain Aging. Front Aging Neurosci (2009) 0.91
Molecular bases of NMDA receptor subtype-dependent properties. J Physiol (2014) 0.91
Potential pathophysiological role of D-amino acid oxidase in schizophrenia: immunohistochemical and in situ hybridization study of the expression in human and rat brain. J Neural Transm (Vienna) (2009) 0.91
Functional and molecular analysis of D-serine transport in retinal Müller cells. Exp Eye Res (2006) 0.91
Persistent astroglial swelling accompanies rapid reversible dendritic injury during stroke-induced spreading depolarizations. Glia (2012) 0.91
Cephalopod vision involves dicarboxylic amino acids: D-aspartate, L-aspartate and L-glutamate. Biochem J (2005) 0.91
D-Amino acid oxidase-mediated increase in spinal hydrogen peroxide is mainly responsible for formalin-induced tonic pain. Br J Pharmacol (2012) 0.91
Emerging role of astroglia in pain hypersensitivity. Jpn Dent Sci Rev (2010) 0.91
Neuronal D-serine regulates dendritic architecture in the somatosensory cortex. Neurosci Lett (2012) 0.91
AMPA receptor mediated D-serine release from retinal glial cells. J Neurochem (2010) 0.90
Visualization of glutamate as a volume transmitter. J Physiol (2010) 0.90
D-serine as a gliotransmitter and its roles in brain development and disease. Front Cell Neurosci (2013) 0.89
Cell-type specific mechanisms of D-serine uptake and release in the brain. Front Synaptic Neurosci (2014) 0.89
Isolation and expression of a rat brain cDNA encoding glutamate carboxypeptidase II. Proc Natl Acad Sci U S A (1998) 0.88
Spatiotemporal analysis of purkinje cell degeneration relative to parasagittal expression domains in a model of neonatal viral infection. J Virol (2006) 0.88
Failure of NMDA receptor hypofunction to induce a pathological reduction in PV-positive GABAergic cell markers. Neurosci Lett (2010) 0.87
Regulated exocytosis in astrocytic signal integration. Neurochem Int (2010) 0.87
Picomolar amyloid-β peptides enhance spontaneous astrocyte calcium transients. J Alzheimers Dis (2014) 0.87
Neuron-astrocyte interactions in the medial nucleus of the trapezoid body. J Gen Physiol (2010) 0.86
Deep brain stimulation: are astrocytes a key driver behind the scene? CNS Neurosci Ther (2014) 0.86
New vistas on astroglia in convulsive and non-convulsive epilepsy highlight novel astrocytic targets for treatment. J Physiol (2012) 0.86
A dialogue between glia and neurons in the retina: modulation of neuronal excitability. Neuron Glia Biol (2004) 0.86
Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes. Br J Pharmacol (2012) 0.86
Crystal structure of a homolog of mammalian serine racemase from Schizosaccharomyces pombe. J Biol Chem (2009) 0.86
Paradoxical roles of serine racemase and D-serine in the G93A mSOD1 mouse model of amyotrophic lateral sclerosis. J Neurochem (2012) 0.86
Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients. PLoS One (2014) 0.86
Synthesis, accumulation, and release of d-aspartate in the Aplysia californica CNS. J Neurochem (2010) 0.85
Overexpression of serum response factor restores ocular dominance plasticity in a model of fetal alcohol spectrum disorders. J Neurosci (2010) 0.85
Serine racemase deletion abolishes light-evoked NMDA receptor currents in retinal ganglion cells. J Physiol (2011) 0.85
Genetic loss of D-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice. Genes Brain Behav (2009) 0.85
Volume transmission signalling via astrocytes. Philos Trans R Soc Lond B Biol Sci (2014) 0.84
Localization of D-serine and serine racemase in neurons and neuroglias in mouse brain. Neurol Sci (2010) 0.84
Astrocytes release D-serine by a large vesicle. Neuroscience (2013) 0.84
D-Serine metabolism in C6 glioma cells: Involvement of alanine-serine-cysteine transporter (ASCT2) and serine racemase (SRR) but not D-amino acid oxidase (DAO). J Neurosci Res (2010) 0.84
Bioluminescent imaging of Ca2+ activity reveals spatiotemporal dynamics in glial networks of dark-adapted mouse retina. J Physiol (2007) 0.84
D-serine treatment reduces cocaine-primed reinstatement in rats following extended access to cocaine self-administration. Neuroscience (2010) 0.84
Glycine and D-serine decrease MK-801-induced hyperactivity in mice. J Neural Transm (Vienna) (1997) 0.83
Overexpression of serine racemase in retina and overproduction of D-serine in eyes of streptozotocin-induced diabetic retinopathy. J Neuroinflammation (2011) 0.83
Roles of quaternary structure and cysteine residues in the activity of human serine racemase. BMC Biochem (2011) 0.83
Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature (1987) 8.89
Modulation of neuronal migration by NMDA receptors. Science (1993) 3.07
Glial cell diversification in the rat optic nerve. Science (1989) 1.82
3H-labeled MK-801 binding to the excitatory amino acid receptor complex from rat brain is enhanced by glycine. Proc Natl Acad Sci U S A (1987) 1.79
Endogenous D-serine in rat brain: N-methyl-D-aspartate receptor-related distribution and aging. J Neurochem (1993) 1.78
Synaptic biochemistry of amino acids. Fed Proc (1973) 1.74
Inhibition of motoneurones by iontophoresis of glycine. Nature (1967) 1.65
Glial cells of the oligodendrocyte lineage express both kainate- and AMPA-preferring subtypes of glutamate receptor. Neuron (1994) 1.58
The glycine site of the NMDA receptor--five years on. Trends Pharmacol Sci (1993) 1.54
The presence of free D-serine in rat brain. FEBS Lett (1992) 1.47
Excitatory amino acids directly depolarize rat brain astrocytes in primary culture. Nature (1984) 1.47
Multiple conductance channels in type-2 cerebellar astrocytes activated by excitatory amino acids. Nature (1989) 1.33
Glycine and glycine receptor immunoreactivity in brain and spinal cord. J Neurosci (1988) 1.32
D-amino acids in animals. Science (1969) 1.27
D-amino-acid oxidase is confined to the lower brain stem and cerebellum in rat brain: regional differentiation of astrocytes. Brain Res (1994) 1.20
Glycine is a coagonist at the NMDA receptor/channel complex. Prog Neurobiol (1990) 1.19
Activation of glutamate receptors and glutamate uptake in identified macroglial cells in rat cerebellar cultures. J Physiol (1991) 1.17
A comparison of the concentration of glycine, a transmitter suspect, in different areas of the brain and spinal cord in seven different vertebrates. Comp Biochem Physiol (1969) 1.13
Extremely high titre polyclonal antisera against small neurotransmitter molecules: rapid production, characterisation and use in light- and electron-microscopic immunocytochemistry. J Neurosci Methods (1993) 1.10
Distribution of free D-serine in vertebrate brains. Brain Res (1994) 1.09
Immunocytochemical evidence for the involvement of glycine in sensory centers of the rat brain. Neuroscience (1992) 0.99
In vivo modulation of the N-methyl-D-aspartate receptor complex by D-serine: potentiation of ongoing neuronal activity as evidenced by increased cerebellar cyclic GMP. J Neurochem (1989) 0.98
Involvement of D-amino acid oxidase in elimination of free D-amino acids in mice. Biochem J (1989) 0.97
Evaluation of the immunocytochemical method for amino acids. Med Biol (1986) 0.97
Astrocyte heterogeneity: endogenous amino acid levels and release evoked by non-N-methyl-D-aspartate receptor agonists and by potassium-induced swelling in type-1 and type-2 astrocytes. J Neurochem (1992) 0.96
Characterization and regional distribution of strychnine-insensitive [3H]glycine binding sites in rat brain by quantitative receptor autoradiography. Neuroscience (1990) 0.95
Modulation of seizure susceptibility in the mouse by the strychnine-insensitive glycine recognition site of the NMDA receptor/ion channel complex. Br J Pharmacol (1990) 0.94
Glycine cleavage system in astrocytes. Brain Res (1991) 0.93
Strychnine, glycine and vertebrate postsynaptic inhibition. Nature (1970) 0.91
Glycine neurons in the brain and spinal cord. Antibody production and immunocytochemical localization. Brain Res (1986) 0.89
In vivo modulation of N-methyl-D-aspartate receptor-dependent long-term potentiation by the glycine modulatory site. Neuroscience (1992) 0.88
Localization of D-amino acid oxidase in Bergmann glial cells and astrocytes of rat cerebellum. Brain Res Bull (1987) 0.88
Regional distribution and properties of the glycine cleavage system within the central nervous system of the rat: evidence for an endogenous inhibitor during in vitro assay. J Neurochem (1976) 0.87
Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci U S A (1990) 10.40
Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol (2001) 9.82
RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell (1994) 8.71
Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature (1991) 8.41
Nitric oxide stimulates auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase. Proc Natl Acad Sci U S A (1992) 8.24
RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc Natl Acad Sci U S A (1998) 8.03
Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature (1990) 7.23
The biotin switch method for the detection of S-nitrosylated proteins. Sci STKE (2001) 6.09
Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci U S A (1989) 6.08
Opiate receptor: demonstration in nervous tissue. Science (1973) 6.06
Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci U S A (1991) 5.70
Carbon monoxide: a putative neural messenger. Science (1993) 5.47
Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem (1994) 5.11
Targeted disruption of the neuronal nitric oxide synthase gene. Cell (1993) 5.02
Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci U S A (1993) 4.73
Characterization of inositol trisphosphate receptor binding in brain. Regulation by pH and calcium. J Biol Chem (1987) 4.46
Solubilization, purification, and characterization of an inositol trisphosphate receptor. J Biol Chem (1988) 4.42
Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors. Proc Natl Acad Sci U S A (1968) 4.24
Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med (1997) 4.12
Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science (1976) 4.07
Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci U S A (1992) 3.95
Dexfenfluramine neurotoxicity in brains of non-human primates. Lancet (1991) 3.94
Nitric oxide, a novel neuronal messenger. Neuron (1992) 3.87
Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science (1994) 3.86
Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci U S A (1999) 3.85
Binding of the inward rectifier K+ channel Kir 2.3 to PSD-95 is regulated by protein kinase A phosphorylation. Neuron (1996) 3.75
D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A (2000) 3.71
Nitric oxide: a physiologic mediator of penile erection. Science (1992) 3.39
Muscarinic cholinergic binding in rat brain. Proc Natl Acad Sci U S A (1974) 3.35
Purified inositol 1,4,5-trisphosphate receptor mediates calcium flux in reconstituted lipid vesicles. Nature (1989) 3.35
Properties of opiate-receptor binding in rat brain. Proc Natl Acad Sci U S A (1973) 3.34
Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci U S A (1996) 3.29
Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci U S A (1993) 3.24
Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci U S A (1991) 3.22
Amine synthesis in regenerating rat liver: extremely rapid turnover of ornithine decarboxylase. Mol Pharmacol (1969) 3.21
Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem (1992) 3.21
Adenosine receptors in brain membranes: binding of N6-cyclohexyl[3H]adenosine and 1,3-diethyl-8-[3H]phenylxanthine. Proc Natl Acad Sci U S A (1980) 3.20
Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. Nature (1995) 3.15
Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission. Proc Natl Acad Sci U S A (1999) 3.15
Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann Neurol (1993) 3.12
Nitric oxide, a novel biologic messenger. Cell (1992) 3.04
A sensitive and specific fluorescence assay for tissue serotonin. Biochem Pharmacol (1965) 2.99
Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. J Biol Chem (1992) 2.97
Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide. J Biol Chem (1993) 2.96
Inositol 1,4,5-trisphosphate receptor localized to endoplasmic reticulum in cerebellar Purkinje neurons. Nature (1989) 2.94
Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates Ca2+ flux. Cell (1995) 2.89
Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol Pharmacol (1979) 2.89
Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci U S A (1985) 2.85
Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci U S A (1999) 2.84
Synthesis of diphosphoinositol pentakisphosphate by a newly identified family of higher inositol polyphosphate kinases. Curr Biol (1999) 2.76
Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc Natl Acad Sci U S A (1992) 2.72
A huntingtin-associated protein enriched in brain with implications for pathology. Nature (1995) 2.67
PIN: an associated protein inhibitor of neuronal nitric oxide synthase. Science (1996) 2.66
Adenosine receptors and behavioral actions of methylxanthines. Proc Natl Acad Sci U S A (1981) 2.66
Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors. Mol Pharmacol (1977) 2.64
Cyclic AMP-dependent phosphorylation of a brain inositol trisphosphate receptor decreases its release of calcium. Proc Natl Acad Sci U S A (1988) 2.63
Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron (1991) 2.60
Adenosine receptors in the central nervous system: relationship to the central actions of methylxanthines. Life Sci (1981) 2.58
Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions. Proc Natl Acad Sci U S A (1988) 2.57
Nitric oxide: a physiologic messenger. Ann Intern Med (1994) 2.50
The odorant-sensitive adenylate cyclase of olfactory receptor cells. Differential stimulation by distinct classes of odorants. J Biol Chem (1986) 2.50
A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann Neurol (1992) 2.47
Strychnine binding associated with glycine receptors of the central nervous system. Proc Natl Acad Sci U S A (1973) 2.37
High affinity transport of choline into synaptosomes of rat brain. J Neurochem (1973) 2.35
Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites. J Biol Chem (1992) 2.34
Nitric oxide synthase: irreversible inhibition by L-NG-nitroarginine in brain in vitro and in vivo. Biochem Biophys Res Commun (1991) 2.33
Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system. Proc Natl Acad Sci U S A (1974) 2.29
Purification of serine racemase: biosynthesis of the neuromodulator D-serine. Proc Natl Acad Sci U S A (1999) 2.27
Opiate agonists and antagonists discriminated by receptor binding in brain. Science (1973) 2.27
Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol Sci (1999) 2.25
Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J Neurosci (1994) 2.25
An endogenous morphine-like factor in mammalian brain. Life Sci (1975) 2.21
Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake. J Pharmacol Exp Ther (1970) 2.21
Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON. Neuron (2000) 2.20
Properties of gamma-aminobutyric acid (GABA) receptor binding in rat brain synaptic membrane fractions. Brain Res (1975) 2.17
Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci (1993) 2.16
Heme oxygenase 2: endothelial and neuronal localization and role in endothelium-dependent relaxation. Proc Natl Acad Sci U S A (1996) 2.15
Morphine-like peptides in mammalian brain: isolation, structure elucidation, and interactions with the opiate receptor. Proc Natl Acad Sci U S A (1976) 2.14
Binding of nerve growth factor receptor in sympathetic ganglia. Proc Natl Acad Sci U S A (1973) 2.14
Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death. Proc Natl Acad Sci U S A (1997) 2.10
Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes. Mol Pharmacol (1976) 2.09
Catecholamine uptake by synaptosomes from rat brain. Structure-activity relationships of drugs with differential effects on dopamine and norepinephrine neurons. Mol Pharmacol (1971) 2.08
Characterization of a membrane protein from brain mediating the inhibition of inositol 1,4,5-trisphosphate receptor binding by calcium. Biochem J (1988) 2.08
Opioid peptide enkephalin: immunohistochemical mapping in rat central nervous system. Proc Natl Acad Sci U S A (1977) 2.07
Cloning and expression of an adenylyl cyclase localized to the corpus striatum. Nature (1993) 2.07
CAPON: a protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95. Neuron (1998) 2.05
The inositol 1,4,5,-trisphosphate receptor in cerebellar Purkinje cells: quantitative immunogold labeling reveals concentration in an ER subcompartment. J Cell Biol (1990) 2.03
The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J Biol Chem (1986) 2.03
Regional distribution of opiate receptor binding in monkey and human brain. Nature (1973) 2.02
High affinity uptake systems for glycine, glutamic and aspaspartic acids in synaptosomes of rat central nervous tissues. Brain Res (1972) 2.01
Opiate receptor: autoradiographic localization in rat brain. Proc Natl Acad Sci U S A (1976) 2.01
Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science (1986) 2.00
Cain, a novel physiologic protein inhibitor of calcineurin. J Biol Chem (1998) 2.00
Drugs, neurotransmitters, and schizophrenia. Science (1974) 2.00
Regional differences in H3-norepinephrine and H3-dopamine uptake into rat brain homogenates. J Pharmacol Exp Ther (1969) 1.99
Calcium flux mediated by purified inositol 1,4,5-trisphosphate receptor in reconstituted lipid vesicles is allosterically regulated by adenine nucleotides. Proc Natl Acad Sci U S A (1990) 1.98
The inositol hexakisphosphate kinase family. Catalytic flexibility and function in yeast vacuole biogenesis. J Biol Chem (2000) 1.98
Molecular mechanisms of nitric oxide regulation. Potential relevance to cardiovascular disease. Circ Res (1993) 1.93
Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat Cell Biol (1999) 1.93
D-serine as a neuromodulator: regional and developmental localizations in rat brain glia resemble NMDA receptors. J Neurosci (1997) 1.93